LNZ Lenzing Aktiengesellschaft
Lenzing Aktiengesellschaft, together with its subsidiaries, produces and markets regenerated cellulosic fibers for textiles and nonwovens. The company operates through Division Fiber, Division Pulp, and Others segments. It offers lyocell, modal, and viscose fibers for application in textiles and nonwovens products, such as denim, activewear, intimates, haute couture and footwear, home and interiors, luxury textiles, and workwear; body care, intimate hygiene comprising baby wipes, surface cleaning, beauty and personal care, facial sheet masks, and cosmetic wipes; and protective clothing, engineered products, packaging, filtration as well as medical and industrial applications, and automotive interiors under the TENCEL, VEOCEL, LENZING ECOVERO, and LENZING brand names. The company also provides biorefinery products, including acetic acid biobased, furfural biobased, magnesium-lignosulphonate biobased, soda ash, sodium sulphate, and xylose. In addition, it engages in training and personnel development activities and converts renewable electricity directly into process heat. The company operates in Austria; rest of Europe; Asia; North, Central, and South America; and internationally. Lenzing Aktiengesellschaft was formerly known as Chemiefaser Lenzing AG and changed its name to Lenzing Aktiengesellschaft in 1984. Lenzing Aktiengesellschaft was founded in 1892 and is headquartered in Lenzing, Austria.…
Industry Peers
Textile ManufacturingKey Statistics
About Lenzing (VIE: LNZ)
›
Lenzing (VIE: LNZ) is listed on the Vienna Stock Exchange, where its shares trade in EUR. It belongs to the Textile Manufacturing industry, part of the Consumer Cyclical sector, and reports about 7,374 employees.
The shares were at 10.22 EUR on 19 November 2026, down 54.4% over 52 weeks. Its 52-week range is 9.850 EUR to 29.80 EUR: the price is 65.7% below the high and 3.8% above the low.
Its market capitalisation is 749.89M EUR.
Lenzing reports return on equity of -17.6%, an operating margin of -0.0% and revenue up 4.4% year over year.
Its debt exceeds its cash by 1.62B EUR, a debt-to-equity ratio of 1.71. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Hold; their mean price target of 19.32 EUR is 89.1% above the current price. The next earnings report is expected on 18 March 2027.